KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Inspection included drug device combinations covering our recent filing in nasal sprays domain
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma (NHL) in adults, represents 40% of all cases worldwide
Subscribe To Our Newsletter & Stay Updated
